Carenostics

Name: Carenostics
Brand: Carenostics

AI Native

Addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML

Est 2021

LinkedIn 1K|Website|Web traffic 2K|FTEs 13|HQ Philadelphia, Pennsylvania, US

01Competitive Landscape

Narrative analysis

Where Carenostics may be selected - Organizations that prioritize a vendor-focused solution aimed at identifying underdiagnosis (starting with CKD) rather than relying exclusively on general EHR vendor tooling. - Organizations that value a vendor-reported approach of tailoring models to each health system; local tailoring can align with lessons learned where broadly trained models underperform without local calibration. Where alternatives may be preferred - Epic native tooling may be preferred when organizations prioritize single-vendor contracting, built-in governance, and minimized third-party integration. - Roche’s algorithm distribution ecosystem may be preferred when organizations want a broader platform that can host multiple algorithms from multiple vendors. - Renalytix may be chosen when the decision is specifically about a reimbursable prognostic CKD test versus an EHR-embedded model. Market adoption signals - Carenostics is early-stage and does not have extensive public review coverage; this often corresponds with fewer public reference customers and more bespoke implementations.

	Carenostics	Epic (native CDS/models)	Renalytix KidneyIntelX
Starting Price	Not public	Not public (bundled/enterprise EHR contracting)	Published per-test pricing available from public sources; pricing and coverage vary
Best For	Health systems seeking a vendor-focused approach for identifying underdiagnosis gaps (e.g., CKD) with workflow prompts	Epic health systems seeking a single-vendor, workflow-integrated CDS solution and governance	Programs seeking a prognostic CKD risk test (esp. T2D+CKD) for stratification and care pathways
Key Strength	Disease-focused identification workflows; vendor states models are tailored to health systems and deployed without transferring patient-level data (vendor claim)	Deep EHR integration; existing governance tools; broad footprint	Defined disease-specific diagnostic/prognostic test with available payer engagement and evolving reimbursement pathways
Key Weakness	Limited public security/compliance documentation and limited public user reviews; early-stage company	Some vendor models have faced criticism around performance and false alarms; customization burden	Requires ordering a specific test; not a general EHR-wide CDS platform; cost per test may be a barrier

01Competitive Landscape

Narrative analysis

Where Carenostics may be selected

Organizations that prioritize a vendor-focused solution aimed at identifying underdiagnosis (starting with CKD) rather than relying exclusively on general EHR vendor tooling.
Organizations that value a vendor-reported approach of tailoring models to each health system; local tailoring can align with lessons learned where broadly trained models underperform without local calibration.

Where alternatives may be preferred

Epic native tooling may be preferred when organizations prioritize single-vendor contracting, built-in governance, and minimized third-party integration.
Roche’s algorithm distribution ecosystem may be preferred when organizations want a broader platform that can host multiple algorithms from multiple vendors.
Renalytix may be chosen when the decision is specifically about a reimbursable prognostic CKD test versus an EHR-embedded model.

Market adoption signals

Carenostics is early-stage and does not have extensive public review coverage; this often corresponds with fewer public reference customers and more bespoke implementations.

	Carenostics	Epic (native CDS/models)	Renalytix KidneyIntelX
Starting Price	Not public	Not public (bundled/enterprise EHR contracting)	Published per-test pricing available from public sources; pricing and coverage vary
Best For	Health systems seeking a vendor-focused approach for identifying underdiagnosis gaps (e.g., CKD) with workflow prompts	Epic health systems seeking a single-vendor, workflow-integrated CDS solution and governance	Programs seeking a prognostic CKD risk test (esp. T2D+CKD) for stratification and care pathways
Key Strength	Disease-focused identification workflows; vendor states models are tailored to health systems and deployed without transferring patient-level data (vendor claim)	Deep EHR integration; existing governance tools; broad footprint	Defined disease-specific diagnostic/prognostic test with available payer engagement and evolving reimbursement pathways
Key Weakness	Limited public security/compliance documentation and limited public user reviews; early-stage company	Some vendor models have faced criticism around performance and false alarms; customization burden	Requires ordering a specific test; not a general EHR-wide CDS platform; cost per test may be a barrier

Carenostics

01Competitive Landscape

Narrative analysis

02Market Map

01Competitive Landscape

Narrative analysis

02Market Map